Understanding eGFR and uPCR is vital for managing IgA nephropathy to predict kidney health, guide treatment, and work effectively with healthcare providers in slowing disease progression.

Diamonds sit at a distinct intersection of emotion and economics. In India, they are bought for weddings, milestones, and family gifting, yet they are also sometimes considered a store of value. Today ...

Rocket Lab (RKLB) has drawn fresh attention after recent share price moves, with the stock showing strong returns over the past year and past 3 months. For context, it is useful to relate that ...

Rocket Lab (RKLB) has quietly turned into one of the market's stronger space names this year, with the stock up around 55% over the past month and 165% over the past year. See our latest analysis for ...

Rocket Lab has won an $816 million contract — its largest to date — with the U.S. Space Development Agency as the company continues to diversify beyond its “rocket company” label. The company said ...

The Q3 has been really poor for the portfolio, where the drawdown since August has been around 10% while the market edged slightly higher by around 3%, therefore significant ground has been lost to ...

In August, I covered Rocket Lab Corporation's (RKLB) earnings. Since then, the stock price has climbed 38%. Feedback I received from readers indicated the desire to see a deeper dive into the ...

Biosero, a BICO company and developer of integrated laboratory automation solutions, signed a master service agreement with a global pharma company in August 2025 and has now received the first ...

“Mama, this basketball game after school is super important. I need you there.” Like any proud mama, I promised I wouldn’t miss it. I even basked in the fact that he still wanted his mom to be there.

Focusing on the research progress of electro-synthetic value-added chemicals, this comment proposes lab strategies to enhance energy conversion efficiency, including catalyst screening, process ...

Investment bank Cantor Fitzgerald, in a report on New Zealand and Long Beach-based Rocket Lab, has raised its price target from $29 to $35. Cantor Fitzgerald analyst Andres Sheppard raised the firm’s ...